GEHC Stock Analysis: Buy, Sell, or Hold?
GEHC - GE HealthCare Technologies Inc. Common Stock
$65.57
0.70 (1.09%)
▲
5d:
+0.96%
30d:
+5.77%
90d:
-8.91%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Jul 29, 2026
25d
Smart Money Distribution
None View Scanner →
Strength: 7.7/10
Get Alerted When GEHC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: GEHC shows positive signals but monitor for confirmation. Market pricing in 4.1% decline. Moderate conviction.
💡 BUY OPPORTUNITY: GEHC shows positive signals but monitor for confirmation. Market pricing in 4.1% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$104.64
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$64.97
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: GEHC is currently trading at $65.56, which is considered extended relative to its 30-day fair value range of $62.38 to $65.23. From a valuation perspective, the stock is trading at a discount (Forward PE: 12.2) compared to its historical average (13.9). Remarkably, the market is currently pricing in an annual earnings decline of 4.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, GEHC is in a strong downtrend. The price is approaching resistance at $66.34. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: GEHC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $79.22 (+20.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GEHC is in a strong downtrend. The price is approaching resistance at $66.34. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: GEHC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $79.22 (+20.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$62.38 -
$65.23
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 20.8% below Wall St target ($79.22)
Trading Range Analysis
30-Day Trading Range
$62.38 -
$65.23
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$59.97
Resistance Level
$66.34
Current Trend
Strong Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.23
Wall Street Target
$79.22
(+20.8%)
Revenue Growth (YoY)
7.4%
Earnings Growth (YoY)
-30.9%
Profit Margin
9.1%
Valuation Discount vs History
-4.1% cheaper
PE vs Historical
12.2 vs 13.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.1%
(market-implied from PE analysis)
1-Year Target
$62.88
(-4%)
2-Year Target
$60.30
(-8%)
3-Year Target
$57.83
(-12%)
3-Yr Target (if PE normalizes)
(PE: 12→14)
$65.71
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 10.1%)
$155.61
(+137%)
Base:
(SPY PE: 12.2, Growth: 10.1%)
$87.39
(+33%)
Bear:
(PE: 10.4, Growth: 10.1%)
$74.28
(+13%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (16x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 15.55 | Current EPS (TTM): $4.17
Bull Case
$91.71
(+40%)
Analyst growth 28.5%, PE expands to 17.1
Base Case
$83.37
(+27%)
Market implied 28.5%, PE stable at 15.6
Bear Case
$44.10
(-33%)
Severe decline -20.0%, PE contracts to 13.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.2 to 13.9
Stabilization Target:
$74.51
(+13.6%)
PE Expansion Potential:
+13.6%
Share & Embed Analysis
Last updated: July 03, 2026 4:35 PM ET
Data refreshes hourly during market hours. Next update: 5:35 PM
Data refreshes hourly during market hours. Next update: 5:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GEHC showing a specific setup today?
Insider Activity (6 Months)
2
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Terri A. Sewell
SELL
2026-03-25
Warren Davidson
SELL
2026-03-23
Ro Khanna
BUY
2026-02-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$75 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 65 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$240 | 65 BUY |
Advanced GEHC Option Strategies
Professional options setups generated by AI based on today's GEHC price and gamma walls.
